ECG App
Electrocardiograph Software For Over-the-counter Use
Apple Inc
The following data is part of a De Novo classification by Apple Inc with the FDA for Ecg App.
Pre-market Notification Details
| DeNovo ID | DEN180044 |
| Device Name: | ECG App |
| Classification | Electrocardiograph Software For Over-the-counter Use |
| Applicant | Apple Inc c/o Biologics Consulting Group 400 N Washington St., Suite 100 Alexandria, VA 22314 |
| Contact | Donna-bea Tillman |
| Product Code | QDA |
| CFR Regulation Number | 870.2345 [🔎] |
| Decision | Granted (DENG) |
| 510(k) Premarket Notification | Device Classification Under Section 513(f)(2)(de Novo) // Quick Links: Skip To Main Page Content Skip To Search Skip To Topics Menu Skip To Common Lin |
| Review Advisory Board | Cardiovascular |
| Classification Advisory | Cardiovascular |
| Type | Direct |
| Date Received | 2018-08-14 |
| Decision Date | 2018-09-11 |
| FDA Review | Decision Summary |
| Reclassification Order: | Reclassification Order |
NIH GUDID Devices
© 2025 FDA.report
This site is not affiliated with or endorsed by the FDA.